Skip to main content
Premium Trial:

Request an Annual Quote

Ninety-Six Early-Career Researchers to Receive Presidential Early Career Awards

Premium

US President Barack Obama today named 96 recipients of the Presidential Early Career Awards for Scientists and Engineers, "the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers," according to a White House statement.

The US National Institutes of Health notes that 20 researchers it supports are among the 96 presidential award recipients. Among those 20 NIH-supported recipients are several researchers working on genomics, including the University of Mississippi Medical Center's Ervin Fox, whose focus is on the clinical and genetic correlates of vascular function in African Americans; Steven Kosak at the Northwestern University Feinberg School of Medicine, who is researching the organization of vertebrate genomes; the National Cancer Institute's Daniel Larson, whose focus is on the transcription dynamics of single human cells; and Erez Lieberman-Aiden from Harvard University, who is investigating how the genome folds through proximity ligation and sequencing, the agency says.

In a statement, NIH Director Francis Collins notes that "this Presidential Award recognizes the achievements of scientists early in their career who show exceptional potential for leadership in science and technology," and that its recipients "have only recently started research in their fields, and they have the potential for long and productive careers working on discoveries to improve the health of our nation."

Obama will present the awards at a White House ceremony this month, NIH adds.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.